已收盤 08-07 16:00:00 美东时间
+0.050
+1.95%
今日重点评级关注:Roth Capital:维持Nuvectis Pharma"买入"评级,目标价从20美元升至33美元;摩根士丹利:维持GXO Logistics"超配"评级,目标价从75美元升至78美元
07-07 11:34
Morgan Stanley analyst Alex Straton reinstates Torrid Holdings (NYSE:CURV) with a Equal-Weight and announces $1.8 price target.
07-07 01:39
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Torrid业绩会实录,以下是Q1财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** Q1净销售额为2.46亿美元,同比下降5.4%(从2.60亿美元下降),但略高于内部指引预期。可比销售额下降1.7%,若排除鞋类业务影响,可比销售额实际增长1.2%。 **盈利能力:** 毛利润为8,680万美元,同比下降1,420万美元;毛利率为35.3%,同比下降280个基点(从38.1%下降)。净利润为41.4万美元,每股收益0.00美元,同比大幅下降(去年同期净利润590万美元,每股收益0.06美元)。 **运营效率:** 调整后EBITDA为
06-05 12:03
On Thursday, Torrid Holdings (NYSE:CURV) discussed first-quarter financial resu...
06-05 05:02
Torrid Holdings shares are trading higher after the company reported better-tha...
06-05 04:36
Torrid Holdings (NYSE:CURV) sees Q2 sales of $232.000 million-$240.000 million vs $245.362 million analyst estimate.
06-05 04:07
Torrid Holdings (NYSE:CURV) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of $(0.01) by 100 percent. This is a 100 percent decrease over earnings of $0.06 per share from the
06-05 04:06
Gainers Torrid Holdings (NYSE:CURV) stock rose 14.4% to $1.43 during Friday's ...
03-20 20:05
Torrid Holdings shares rose 20% in after-hours trading after reporting full-year EBITDA that topped guidance despite a net loss.
03-20 14:02
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Torrid业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **全年2025年业绩:** - 净销售额:10亿美元,达到指导区间上限 - 调整后EBITDA:6,360万美元,超出指导区间上限 - 年末现金及现金等价物:2亿美元 - 年末库存:1.365亿美元,同比下降8% **第四季度业绩:** - 净销售额:2.362亿美元,同比下降14.3%(前年同期2.756亿美元) - 毛利润:7,090万美元,同比下降23.4%(前年同期9,260万美元) - 净亏损:810万美元(每股0.08美元),亏损扩大(前年同期净亏损300万美元
03-20 12:17